Shashanka Vangari

Shashanka Vangari has a strong background in quality assurance and compliance within the pharmaceutical industry. Shashanka'smost recent role was as a Director of GCP/PVG QA at SK Life Science, Inc. where they started in November 2022. Prior to that, they served as a Director of Research & Clinical Development Operations at Alexion Pharmaceuticals, Inc. from September 2020 to June 2022. Shashanka also held the position of Associate Director of GCP/GLP Compliance at Seattle Genetics from March 2017 to March 2020. Shashanka has experience in regulatory affairs, clinical operations, and quality systems as a Director of Compliance Operations at Trillium Technologies Group Inc. from April 2013 to May 2015. Additionally, they have worked as a Consultant in Regulatory Affairs & Clinical Operations at PharmEng Technology Inc. from June 2009 to August 2011. Shashanka's expertise also includes roles in QA and regulatory affairs at Protox Therapeutics, Biological E Limited, and Tekmira Pharmaceutical Corporation.

Shashanka Vangari completed their M.Sc degree in Microbiology, Biochemistry, Industrial Microbiology, Biostatistics, Environmental Microbiology, and Immunology from Acharya Nagarjuna University between 1992 and 1994. Before attending university, their educational background includes studying at Valerian Grammar School, although specific details about the degree or field of study are not provided.